Study in healthy males to assess bioavailability of single fostamatinib with iv micro tracer dose

Exclusion Criteria

• - History of any clinically significant disease or disorder
• - History or presence of GI, hepatic, or renal disease or any other condition known to interfere with absorption, distribution, metabolism, or excretion of drugs
• - Any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of drug
• - Volunteers who smoke more than 5 cigarettes or the equivalent in tobacco per day
• - Any clinically significant abnormalities in clinical chemistry, hematology or urinalysis results as judged by the Investigator